Vestal Point Capital’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-525,000
Closed -$33M 69
2023
Q4
$33M Buy
+525,000
New +$33M 3.49% 10